Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.
CITATION STYLE
Etemadifar, M., Salari, M., Saeri, M., Sigari, A. A., & Ebrahimi Pelarti, S. (2021). Rituximab induced cytokine release syndrome in an MS patient: A case report. Clinical Case Reports, 9(7). https://doi.org/10.1002/ccr3.4407
Mendeley helps you to discover research relevant for your work.